How Was This Conclusion Made?
A study was conducted involving 5,297 patients who were prescribed blood pressure medications. This study was conducted at the University of Glasgow in Scotland. The people, who were taking the medication for hypertension were followed for a total of 16 years. This study was carried out under the direction of John L Reid, a professor at the college.
There were 1,559 patients involved in the study who were given an ACE inhibitor, while all of the other patients were given other various types of antihypertensive agents. The result for the patients that took the ACE inhibitor showed that there were 60 cancers. It was also found that from this group of patients that the risk of death was one-third less for cancer than the other group involved in the study. The woman who were in the ACE inhibitor group also showed that had only half the risk of cancer-related death. This also concludes that one-third of them risk death from ovarian disease and breast cancer.
The rest of the patients who were part of the study were in the group that were given various other types of antihypertensive agents. For this group, the study concluded that there were 267 cancers. This is where the conclusion was link to renal cancer. This type of cancer is very rare in people under the age of 50.
Dr Reid says that one theory why the ACE inhibitor group was protected was because the ACE inhibitors has a substance in the medication that blocks angiotensin ll, this substance is known to stimulate cells to divide blocking, and that is protective. This agent also blocks blood vessel growth.